skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar solo
Refinado por: materia: Rheumatoid Arthritis eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis
A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis
Material Type:
Artículo 		Añadir a Mi Portal

A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis

Weinblatt, Michael E. ; McInnes, Iain B. ; Kremer, Joel M. ; Miranda, Pedro ; Vencovsky, Jiri ; Guo, Xiang ; White, Wendy I. ; Ryan, Patricia C. ; Godwood, Alex ; Albulescu, Marius ; Close, David ; Burmester, Gerd R.

Arthritis & rheumatology (Hoboken, N.J.), 2018-01, Vol.70 (1), p.49-59 [Revista revisada por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponible

Citas Citado por
2
The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region
The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region
Material Type:
Artículo 		Añadir a Mi Portal

The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region

Mariette, X ; Vencovsky, J ; Lortholary, O ; Gomez-Reino, J ; de Longueville, M ; Ralston, P ; Weinblatt, M ; van Vollenhoven, R

Rheumatic & musculoskeletal diseases open, 2015-01, Vol.1 (1), p.e000044-e000044 [Revista revisada por pares]

England: BMJ Publishing Group LTD

Texto completo disponible

Citas Citado por
3
Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody: Long-Term Safety and Efficacy in Patients With Rheumatoid Arthritis
Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody: Long-Term Safety and Efficacy in Patients With Rheumatoid Arthritis
Material Type:
Artículo 		Añadir a Mi Portal

Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody: Long-Term Safety and Efficacy in Patients With Rheumatoid Arthritis

Burmester, Gerd R ; McInnes, Iain B ; Kremer, Joel M ; Miranda, Pedro ; Vencovský, Jiří ; Godwood, Alex ; Albulescu, Marius ; Michaels, M Alex ; Guo, Xiang ; Close, David ; Weinblatt, Michael

Arthritis & rheumatology (Hoboken, N.J.), 2018-05, Vol.70 (5), p.679-689 [Revista revisada por pares]

United States: John Wiley and Sons Inc

Texto completo disponible

Citas Citado por
4
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial
Material Type:
Artículo 		Añadir a Mi Portal

Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial

Smolen, J ; Landewé, R B ; Mease, P ; Brzezicki, J ; Mason, D ; Luijtens, K ; van Vollenhoven, R F ; Kavanaugh, A ; Schiff, M ; Burmester, G R ; Strand, V ; Vencovský, J ; van der Heijde, D

Annals of the rheumatic diseases, 2009-06, Vol.68 (6), p.797-804 [Revista revisada por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponible

Citas Citado por
5
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Material Type:
Artículo 		Añadir a Mi Portal

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

Aletaha, Daniel ; Neogi, Tuhina ; Silman, Alan J ; Funovits, Julia ; Felson, David T ; Bingham, Clifton O ; Birnbaum, Neal S ; Burmester, Gerd R ; Bykerk, Vivian P ; Cohen, Marc D ; Combe, Bernard ; Costenbader, Karen H ; Dougados, Maxime ; Emery, Paul ; Ferraccioli, Gianfranco ; Hazes, Johanna MW ; Hobbs, Kathryn ; Huizinga, Tom WJ ; Kavanaugh, Arthur ; Kay, Jonathan ; Kvien, Tore K ; Laing, Timothy ; Mease, Philip ; Ménard, Henri A ; Moreland, Larry W ; Naden, Raymond L ; Pincus, Theodore ; Smolen, Josef S ; Stanislawska-Biernat, Ewa ; Symmons, Deborah ; Tak, Paul P ; Upchurch, Katherine S ; Vencovský, Jiří ; Wolfe, Frederick ; Hawker, Gillian

Annals of the rheumatic diseases, 2010-09, Vol.69 (9), p.1580-1588 [Revista revisada por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponible

Citas Citado por
6
Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial
Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial
Material Type:
Artículo 		Añadir a Mi Portal

Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial

Tjärnlund, Anna ; Tang, Quan ; Wick, Cecilia ; Dastmalchi, Maryam ; Mann, Herman ; Tomasová Studýnková, Jana ; Chura, Radka ; Gullick, Nicola J ; Salerno, Rosaria ; Rönnelid, Johan ; Alexanderson, Helene ; Lindroos, Eva ; Aggarwal, Rohit ; Gordon, Patrick ; Vencovsky, Jiri ; Lundberg, Ingrid E

Annals of the rheumatic diseases, 2018-01, Vol.77 (1), p.55-62 [Revista revisada por pares]

England: BMJ Publishing Group LTD

Texto completo disponible

Citas Citado por
7
Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study
Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study
Material Type:
Artículo 		Añadir a Mi Portal

Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study

Fleischmann, R ; Vencovsky, J ; van Vollenhoven, R F ; Borenstein, D ; Box, J ; Coteur, G ; Goel, N ; Brezinschek, H-P ; Innes, A ; Strand, V

Annals of the rheumatic diseases, 2009-06, Vol.68 (6), p.805-811 [Revista revisada por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponible

Citas Citado por
8
Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis
Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis
Material Type:
Artículo 		Añadir a Mi Portal

Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis

Šenolt, Ladislav ; Polanská, Markéta ; Filková, Maria ; Cerezo, Lucie Andrés ; Pavelka, Karel ; Gay, Steffen ; Haluzík, Martin ; Vencovský, Jiří

Annals of the rheumatic diseases, 2010-07, Vol.69 (7), p.1410-1411 [Revista revisada por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponible

Citas Citado por
9
Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study
Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study
Material Type:
Artículo 		Añadir a Mi Portal

Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study

Hurnakova, Jana ; Hulejova, Hana ; Zavada, Jakub ; Hanova, Petra ; Komarc, Martin ; Mann, Herman ; Klein, Martin ; Sleglova, Olga ; Olejarova, Marta ; Forejtova, Sarka ; Ruzickova, Olga ; Vencovsky, Jiri ; Pavelka, Karel ; Senolt, Ladislav Tiziani, Stefano

PloS one, 2017-08, Vol.12 (8), p.e0183420-e0183420 [Revista revisada por pares]

United States: Public Library of Science

Texto completo disponible

Citas Citado por
10
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Material Type:
Artículo 		Añadir a Mi Portal

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Sparks, Jeffrey A ; Wallace, Zachary S ; Seet, Andrea M ; Gianfrancesco, Milena A ; Izadi, Zara ; Hyrich, Kimme L ; Strangfeld, Anja ; Gossec, Laure ; Carmona, Loreto ; Mateus, Elsa F ; Lawson-Tovey, Saskia ; Trupin, Laura ; Rush, Stephanie ; Katz, Patricia ; Schmajuk, Gabriela ; Jacobsohn, Lindsay ; Wise, Leanna ; Gilbert, Emily L ; Duarte-García, Ali ; Valenzuela-Almada, Maria O ; Pons-Estel, Guillermo J ; Isnardi, Carolina A ; Berbotto, Guillermo A ; Hsu, Tiffany Y -T ; D’Silva, Kristin M ; Patel, Naomi J ; Kearsley-Fleet, Lianne ; Schäfer, Martin ; Ribeiro, Sandra Lúcia Euzébio ; Al Emadi, Samar ; Tidblad, Liselotte ; Scirè, Carlo Alberto ; Raffeiner, Bernd ; Thomas, Thierry ; Flipo, René-Marc ; Avouac, Jérôme ; Seror, Raphaèle ; Bernardes, Miguel ; Cunha, Maria Margarida ; Hasseli, Rebecca ; Schulze-Koops, Hendrik ; Müller-Ladner, Ulf ; Specker, Christof ; Souza, Viviane Angelina de ; Mota, Licia Maria Henrique da ; Gomides, Ana Paula Monteiro ; Dieudé, Philippe ; Nikiphorou, Elena ; Kronzer, Vanessa L ; Singh, Namrata ; Ugarte-Gil, Manuel F ; Wallace, Beth ; Akpabio, Akpabio ; Thomas, Ranjeny ; Bhana, Suleman ; Costello, Wendy ; Grainger, Rebecca ; Hausmann, Jonathan S ; Liew, Jean W ; Sirotich, Emily ; Sufka, Paul ; Robinson, Philip C ; Machado, Pedro M ; Yazdany, Jinoos

Annals of the rheumatic diseases, 2021-09, Vol.80 (9), p.1137-1146 [Revista revisada por pares]

England: BMJ Publishing Group LTD

Texto completo disponible

Citas Citado por
Resultados 1 2 3 4 5 next page

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Mostrar solo

  1. Revistas arbitradas (838)

Refinar mis resultados

Tipo de Recurso 

  1. Artículos  (855)
  2. Actas de Congreso  (3)
  3. Artículos de boletín  (1)
  4. Capítulos de libro  (1)
  5. Más opciones open sub menu

Fecha de Publicación 

De Hasta
Refinar
  1. Antes de2003  (9)
  2. 2003Hasta2007  (58)
  3. 2008Hasta2012  (109)
  4. 2013Hasta2018  (327)
  5. Después de 2018  (358)
  6. Más opciones open sub menu

Idioma 

  1. Inglés  (849)
  2. Japonés  (87)
  3. Español  (5)
  4. Portugués  (4)
  5. Ruso  (2)
  6. Noruego  (2)
  7. Turco  (2)
  8. Francés  (1)
  9. Italiano  (1)
  10. Alemán  (1)
  11. Chino  (1)
  12. Más opciones open sub menu

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora